The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value
This study demonstrates that PHI outperforms PSA in detecting PCa, with elevated PHI levels correlating with more advanced disease. Furthermore, combining PHI with mpMRI significantly enhances the detection rate of PCa, particularly among patients with low PSA levels.
Authors
- Yin-Zhi Chen
- Junhui Jiang (ORCID: https://orcid.org/0000-0003-1319-8813)
- Xiaolong Jia (ORCID: https://orcid.org/0000-0001-9687-6872)
- Suying Wang (ORCID: https://orcid.org/0000-0002-5800-8035)
- Zhenya Zhao
- Qi Ma (ORCID: https://orcid.org/0000-0002-5350-0362)
- Rui Su (ORCID: https://orcid.org/0000-0002-8810-495X)
- Dawei Ren
- Jin-feng Pan
Institutions
- Ningbo University (CN)
- University of Nottingham Ningbo China (CN)
- Ningbo Center for Disease Control and Prevention (CN)
- Ningbo University Affiliated Hospital (CN)
- Ningbo First Hospital (CN)
Publication Details
- Journal
- World Journal of Urology
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1007/s00345-025-06003-7
- Citations
- 2
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Ningbo University